PDB ID | 3QD6 | CHAIN | R |
---|---|---|---|
Protein name | Tumor necrosis factor receptor superfamily member 5 | ||
Uniprot Accession | P25942 | ||
The number of similar proteins | 8 | ||
The number of binding states | 5 | ||
The number of binding partners | 4 |
Unicolor (beige)
The number of binding partners
Group
Binding state |
Binding partners |
---|---|
3QD6 (CHAIN: R) | |
1 | P29965 P29965 |
2 | 7P3I |
3 | 5DMJ |
4 | 6PE8 6PE8 |
5 | 6FAX 6FAX |
Only interaction residues |
|
||||||||||
|
Residue | AA | Source | dbSNP | Clinical Significance |
Allele Frequency (> 0.0001) |
Disease name | |
---|---|---|---|---|---|---|---|
26_CYS | GLN | VAR_039301 |
-
|
US | - | Bladder carcinoma cell line Hu549 | |
35_SER | GLY | VAR_039302 |
rs750234130
|
US | - | Bladder carcinoma cell line Hu549 | |
37_CYS | GLY | VAR_077569 |
-
|
LP/P | - | Immunodeficiency with hyper-IgM 3 (HIGM3) [MIM:606843] | |
39_SER | THR | VAR_039303 |
-
|
US | - | Bladder carcinoma cell line Hu549 | |
53_GLU | TER |
ClinVar chr20:44750898 |
-
|
Pathogenic | - | not provided [MedGen:C3661900] | |
83_CYS | ARG | VAR_013628 |
rs28931586
|
LP/P | - | Immunodeficiency with hyper-IgM 3 (HIGM3) [MIM:606843] | |
83_CYS | ARG |
ClinVar chr20:44750988 |
rs28931586
|
Pathogenic | - | Hyper-IgM syndrome type 3 [MONDO:MONDO:0011735,MedGen:C1720957,OMIM:606843,Orphanet:101090] | |
90_ARG | GLN |
gnomAD chr20:44751261 |
rs761229326
|
- | 0.000143181 | - | |
90_ARG | GLN |
8.3kJPN chr20:44751261 |
rs761229326
|
- | 0.0001 | - | |
102_ILE | MET |
8.3kJPN chr20:44751298 |
-
|
- | 0.0001 | - | |
124_SER | LEU | VAR_018751 |
rs11569321
|
LB/B | - | - | |
124_SER | LEU |
gnomAD chr20:44751363 |
rs11569321
|
- | 0.0104388 | - | |
134_ILE | PHE |
8.3kJPN chr20:44751392 |
-
|
- | 0.0001 | - | |
136_THR | THR |
ClinVar chr20:44751769 |
rs2145595063
|
Pathogenic | - | Hyper-IgM syndrome type 3 [MONDO:MONDO:0011735,MedGen:C1720957,OMIM:606843,Orphanet:101090] |